Orapred ODT Alternatives Compared
| Orapred ODT (prednisolone) | Stelara (ustekinumab) | Lialda (mesalamine) |
|
|---|
| Orapred ODT (prednisolone) | Stelara (ustekinumab) | Lialda (mesalamine) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Asthma - acute, Bronchopulmonary Dysplasia, Bullous Pemphigoid, Dermatitis, Crohn's Disease - Active, Immunosuppression, Infantile Spasms, Inflammatory Conditions, Multiple Sclerosis... View more |
Prescription only
Stelara is an immunosuppressant medication that works by binding to two inflammatory cytokines, IL-12 and IL-23, which have been identified as important contributors to chronic inflammation. Stelara... View more |
Prescription only
Prescribed for Ulcerative Colitis - Active, Ulcerative Colitis - Maintenance, Inflammatory Bowel Disease, Ulcerative Proctitis, Ulcerative Colitis. Lialda may also be used for purposes not listed in... View more |
Related suggestions Ulcerative Colitis, Active
|
|||||||||||||||||||||||
| More about Orapred ODT (prednisolone) | More about Stelara (ustekinumab) | More about Lialda (mesalamine) | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Be the first to share your experience with this drug. |
Stelara has an average rating of 7.6 out of 10 from a total of 247 ratings on Drugs.com. 71% of reviewers reported a positive effect, while 15% reported a negative effect. |
Lialda has an average rating of 7.0 out of 10 from a total of 105 ratings on Drugs.com. 60% of reviewers reported a positive effect, while 21% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
N/A |
||||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Orapred ODT prices |
View all Stelara prices |
View all Lialda prices |
||||||||||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Other prednisolone brands include: Millipred, Millipred DP, PediaPred | Other ustekinumab brands include: Imuldosa, Otulfi, Pyzchiva, Selarsdi, Wezlana | Other mesalamine brands include: Apriso, Asacol, Asacol HD, Canasa, Canasa Pac, Delzicol, Pentasa, Rowasa, Rowasa Sulfite Free, Zaldyon View more | ||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
4 hours |
1291.2 hours |
10 hours |
||||||||||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
Excluding Asacol And Asacol HD
Category C
Risk cannot be ruled out
Asacol And Asacol HD See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 596 drugs are known to interact with Orapred ODT:
|
A total of 525 drugs are known to interact with Stelara:
|
A total of 121 drugs are known to interact with Lialda:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
June 01, 2006 |
September 25, 2009 |
January 16, 2007 |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
|
N/A |
N/A |
|||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.